ADT	androgen deprivation therapy
AR	androgen receptor
ARE	androgen receptor element
BPH	benign prostatic hyperplasia
CRPC	castration-resistant prostate cancer
CYP17	cytochrome P450-17
DHEA	dehydroepiandrosterone
DHT	dihydrotestosterone
GABAA	gamma-aminobutyric acid type A
LBD	ligand binding domain
LHRH	luteinizing hormone-releasing hormone
m-CRPC	metastatic castration-resistant prostate cancer
nm-CRPC	non-metastatic castration-resistant prostate cancer
NSAA	non-steroidal antiandrogen
PCa	prostate cancer
PSA	Prostate specific antigen
PSAD	prostate-specific antigen density
PSAV	prostate-specific antigen velocity
SAA	steroid antiandrogen